by Andreas Kremer | Feb 15, 2022
ITTM is participating in the COST action CA202117 Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer. It’s the first Mye-InfoBank hybrid workgroup meeting in Lisbon. It will be accompanied by the second MC meeting and the...
